Effect of plasma fibronectin, macrophages, and glycosaminoglycans on tumor cell growth.

Abstract:

:Fibronectin (Fn) synergizes with macrophages (M phi) in inducing cytostasis and cytotoxicity of neoplastic cells in culture. Since heparin enhances Fn's opsonic activity in many systems, we investigated its effect on Fn-macrophage synergy in cytostasis. MCG-T14 (a spontaneous mouse mammary adenocarcinoma) cells (4 X 10(4] were added to wells both with and without C. parvum activated M phi monolayers. To these cultures were added increasing concentrations of Fn with or without heparin. Fn synergizes with both M phi S and heparin in inhibiting tumor cell growth. The combined cytostatic effect of Fn, heparin and M phi S is more than additive. In other experiments, MCG-T14 cells were pre-incubated for 2 hr with Fn, washed free of Fn, and treated as above. The results of these experiments were similar to coculture experiments, but the effect of heparin was even more pronounced. Dermatan sulfate and hyaluronic acid had a variable effect on Fn and Fn-macrophage induced cytostasis.

journal_name

Cancer Invest

journal_title

Cancer investigation

authors

Martin DE,Reece M,Reese AC

doi

10.3109/07357908409040310

subject

Has Abstract

pub_date

1984-01-01 00:00:00

pages

339-45

issue

5

eissn

0735-7907

issn

1532-4192

journal_volume

2

pub_type

杂志文章
  • Heterogeneity in TPA-induced differentiation of B-chronic lymphocytic leukemia cells: development of hairy cell or plasmacytoid features are time and dose dependent.

    abstract::Cells from 11 chronic lymphocytic leukemic (CLL) patients were induced to differentiate with various doses of tetradecanoyl phorbol-13-acetate (TPA) and the degree of induction was followed up to six days by measuring the expression of two surface membrane markers (SmIg and GP-70), Ig secretion, tartrate-resistant aci...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:

    authors: Gazitt Y,Gurfel D,Leizerowitz R,Feinstein H,Polliack A

    更新日期:1987-01-01 00:00:00

  • Disialoganglioside directed immunotherapy of neuroblastoma.

    abstract::Achieving a cure for metastatic neuroblastoma remains a challenge despite sensitivity to chemotherapy and radiotherapy. Most patients achieve remission, but a failure to eliminate minimal residual disease (MRD) often leads to relapse. Immunotherapy is potentially useful for chemotherapy-resistant disease and may be pa...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357900601130763

    authors: Modak S,Cheung NK

    更新日期:2007-02-01 00:00:00

  • Methylated tumor-specific DNA as a plasma biomarker in patients with glioma.

    abstract:OBJECTIVE:Patients with systemic malignancies have substantial quantities of tumor-specific DNA in their plasma which may serve as a potential biomarker for tumor burden. This approach has not been studied in gliomas. METHODS:Methylation specific polymerase chain reaction (MSP) was used to determine the methylation st...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900500449546

    authors: Weaver KD,Grossman SA,Herman JG

    更新日期:2006-02-01 00:00:00

  • Telomere biology of pediatric cancer.

    abstract::One of the hallmarks of cancer is limitless proliferative capacity, which is tightly associated with the ability to maintain telomeres. Over the last decade, the telomere biology of pediatric cancers has begun to be elucidated. Most pediatric leukemias and embryonal solid tumors activate the enzyme telomerase, a speci...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1080/07357900701208683

    authors: Tabori U,Dome JS

    更新日期:2007-04-01 00:00:00

  • Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines.

    abstract:PURPOSE:Human chondrosarcomas are generally resistant to conventional treatments like chemotherapy and radiotherapy. We investigated the effects of BIBR1532, an inhibitor of telomerase on chondrosarcoma cells in vitro. METHODS:Telomerase activity, telomere lengths, growth kinetics and chemosensitivity were analyzed in...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900802072905

    authors: Parsch D,Brassat U,Brümmendorf TH,Fellenberg J

    更新日期:2008-07-01 00:00:00

  • 5-Fluorouracil and high-dose calcium leucovorin for hepatocellular carcinoma: a phase II trial.

    abstract::A phase II trial of 5-fluorouracil (5-FU) [250-450 mg/m2/day x 5 days as an intravenous (IV) bolus] combined with calcium leucovorin (500 mg/m2/day x 5 1/2 days by continuous IV infusion) administered on a 28-day schedule was performed in 15 patients with advanced hepatocellular carcinoma. The median age was 58 years;...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章

    doi:10.3109/07357909509024907

    authors: Tetef M,Doroshow J,Akman S,Coluzzi P,Leong L,Margolin K,Morgan RJ Jr,Raschko J,Shibata S,Somlo G

    更新日期:1995-01-01 00:00:00

  • Evaluation of Cytotoxic Potentials of Novel Cyclooxygenase-2 Inhibitor against ALL Lymphocytes and Normal Lymphocytes and Its Anticancer Effect through Mitochondrial Pathway.

    abstract::In the present study, we searched selective cytotoxicity and mitochondria mediated apoptosis of novel COX-2 inhibitor 2-(4-(Methylsulfonyl)phenyl)imidazo[1,2-a] pyridine-8-carboxylic acid on B-lymphocytes and their mitochondria isolated from normal subjects and acute lymphoblastic leukemia (ALL) patients' blood. Our r...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2020.1808898

    authors: Salimi A,Aghvami M,Azami Movahed M,Zarei MH,Eshghi P,Zarghi A,Pourahmad J

    更新日期:2020-09-01 00:00:00

  • Inhibition of vascular endothelial growth factor by octreotide in colorectal cancer patients.

    abstract::Vascular endothelial growth factor (VEGF) seems to be essential for angiogenesis and for the growth of colorectal cancer; thus its inhibition can arrest tumor growth and decrease metastatic potential. Octreotide has been shown to inhibit growth of colorectal tumors in vitro and in vivo. Part of the antiproliferative a...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1081/cnv-100000069

    authors: Cascinu S,Del Ferro E,Ligi M,Staccioli MP,Giordani P,Catalano V,Agostinelli R,Muretto P,Catalano G

    更新日期:2001-01-01 00:00:00

  • A phase I trial of chlorambucil administered in short pulses in patients with advanced malignancies.

    abstract::We carried out a phase I trial with chlorambucil. Thirty patients with advanced cancer were entered in six dose levels: 36, 48, 60, 84, 108, and 144 mg/m2. The drug was given in six divided oral doses every 6 hours and the regimen was repeated every 3 weeks. The median age was 62 years (31-84), median Karnofsky perfor...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908809080064

    authors: Blumenreich MS,Woodcock TM,Sherrill EJ,Richman SP,Gentile PS,Epremian BE,Kubota TT,Allegra JC

    更新日期:1988-01-01 00:00:00

  • Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: report of two cases and review of literature.

    abstract::Placement of carmustine-impregnated wafers has become a common practice after surgical resection of malignant gliomas. Bevacizumab is used as a second-line agent for the treatment of malignant gliomas and is sometimes used in patients who have had recent wafer implantation. We describe two cases of fatal cerebrospinal...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357907.2010.483499

    authors: Nagaiah G,Almubarak M,Khan M,Altaha R

    更新日期:2010-12-01 00:00:00

  • Shorter symptom assessment instruments: the Condensed Memorial Symptom Assessment Scale (CMSAS).

    abstract:BACKGROUND:Rapid and efficient symptom assessment is an important aspect of palliative care. The objective was to determine whether a smaller number of symptoms from the 32-item Memorial Symptom Assessment Scale Short-Form (MSAS-SF) could convey equivalent quality of life (QOL) information. METHODS:Responses from 479 ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1081/cnv-200026487

    authors: Chang VT,Hwang SS,Kasimis B,Thaler HT

    更新日期:2004-01-01 00:00:00

  • Low energy proton beam induces efficient cell killing in A549 lung adenocarcinoma cells.

    abstract::The aim of the current study was to determine the signaling differences between gamma- and proton beam-irradiations. A549 lung adenocarcinoma cells were irradiated with 2 Gy proton beam or gamma-radiation. Proton beam was found to be more cytotoxic than gamma-radiation. Proton beam-irradiated cells showed phosphorylat...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357901003630991

    authors: Ghosh S,Bhat NN,Santra S,Thomas RG,Gupta SK,Choudhury RK,Krishna M

    更新日期:2010-07-01 00:00:00

  • Digital dermatoglyphics in mammary cancer.

    abstract::Fingerprints from 200 women with histologically proven breast cancer (case group) were compared to fingerprints from 138 women with no history of any malignant disease (control group). Of the patterns analyzed, four were significantly associated with breast cancer: accidentals, transitionals, angled ulnar loops, and h...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357908809077025

    authors: Bierman HR,Faith MR,Stewart ME

    更新日期:1988-01-01 00:00:00

  • Introduction to genetic linkage analysis.

    abstract::Advances in molecular methodology have resulted in the successful genetic mapping and isolation of the genes responsible for numerous simple Mendelian disorders such as cystic fibrosis, neurofibromatosis, and Huntington disease. Recently, researchers have begun to successfully study diseases with more complex inherita...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909709047596

    authors: Foroud T

    更新日期:1997-01-01 00:00:00

  • Knockdown of CXCR4 Inhibits CXCL12-Induced Angiogenesis in HUVECs through Downregulation of the MAPK/ERK and PI3K/AKT and the Wnt/β-Catenin Pathways.

    abstract::CXCL12 is an extracellular chemokine binding to cell surface receptor CXCR4. We found that activation of CXCL12/CXCR4 axis stimulated angiogenesis in endothelial cells. Knockdown of CXCR4 in endothelial cells prevented the branch points of angiogenesis. Endothelial cells exposed to CXCL12 presented high level of epide...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357907.2017.1422512

    authors: Song ZY,Wang F,Cui SX,Qu XJ

    更新日期:2018-01-02 00:00:00

  • CD133 negatively regulates tumorigenicity via AKT pathway in synovial sarcoma.

    abstract::Synovial sarcoma (SS) is an aggressive tumor that accounts for almost 10% of all soft tissue sarcomas. In this study, we found the expression of CD133 in human SS specimens, thus, we focused on the function of CD133 in SS. Separation of the CD133-positive and -negative subpopulations in SS cell lines clarified that th...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2012.672607

    authors: Kimura T,Wang L,Tabu K,Nishihara H,Mashita Y,Kikuchi N,Tanino M,Hiraga H,Tanaka S

    更新日期:2012-06-01 00:00:00

  • Transgenic nude mouse with green fluorescent protein expression-based human glioblastoma multiforme animal model with EGFR expression and invasiveness.

    abstract::Previously, we developed an orthotopic xenograft model of human glioblastoma multiforme (GBM) with high EGFR expression and invasiveness in Balb/c nu/nu nude mice. Now we also developed the same orthotopic xenograft model in transgenic nude mice with green fluorescent protein (GFP) expression. The present orthotopic x...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2012.697232

    authors: Tan GW,Lan FL,Gao JG,Jiang CM,Zhang Y,Huang XH,Ma YH,Shao HD,He XY,Chen JL,Long JW,Xiao HS,Guo ZT,Diao Y

    更新日期:2012-08-01 00:00:00

  • Overexpression of glucose transporter-1 (GLUT-1) predicts poor prognosis in epithelial ovarian cancer.

    abstract::Illumina microarray was used to identify differentially expressed genes in three epithelial ovarian cancer (EOC) cells. To validate the microarray data, mRNA and protein level of glucose transporter-1 (GLUT-1) was examined. GLUT-1 had an EOC/normal cells ratio of 5.51 based on microarray. Real-time PCR and immunohisto...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2013.849722

    authors: Cho H,Lee YS,Kim J,Chung JY,Kim JH

    更新日期:2013-11-01 00:00:00

  • Breast cancer metastatic to the uterine cervix: analysis of a rare event.

    abstract::A patient with cervical metastases leading to the diagnosis of a primary breast cancer is presented. To better define the frequency, symptoms, and characteristics of breast cancer metastasizing to the uterine cervix, all cases reported in the literature since 1950 are reviewed. This analysis reveals that in 21% of the...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.3109/07357909909032855

    authors: Hepp HH,Hoos A,Leppien G,Wallwiener D

    更新日期:1999-01-01 00:00:00

  • Interventional procedures for cancer pain management: when are they indicated?

    abstract::Non-invasive pharmacological management of patients with cancer related pain has resulted in pain control in 90-95% of the patients. Thus, 5-10% of patients still experience inadequate pain control despite aggressive combined pharmacological therapy. Moreover, patients may not tolerate an aggressive program of titrati...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-200027166

    authors: de Leon-Casasola OA

    更新日期:2004-01-01 00:00:00

  • Three case reports of hand-foot syndrome with gefitinib.

    abstract::Hand-Foot Syndrome (HFS) is commonly reported in treatment with liposomal doxorubicin (LD) and capecitabine. We present 3 cases of HFS recall with gefitinib after previous LD therapy. The first 2 cases, in patients with head and neck cancer previously treated with paclitaxel and LD, developed on subsequent therapy wit...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1080/07357900600814847

    authors: Razis E,Karina M,Karanastassi S,Fountzilas G

    更新日期:2006-08-01 00:00:00

  • Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Outcome of Immune Checkpoint Inhibitors.

    abstract::A meta-analysis of 14 studies (16 cohorts) incorporating 1751 participants was performed to evaluate the correlation between baseline neutrophil-to-lymphocyte ratio (NLR) and outcome of immune checkpoint inhibitors (ICI). The pooled hazard ratio (HR) suggested elevated pretreatment NLR was associated with poor OS (HR:...

    journal_title:Cancer investigation

    pub_type: 杂志文章,meta分析

    doi:10.1080/07357907.2019.1639057

    authors: Xie X,Liu J,Yang H,Chen H,Zhou S,Lin H,Liao Z,Ding Y,Ling L,Wang X

    更新日期:2019-01-01 00:00:00

  • MiR-125a/b regulates the activation of cancer stem cells in paclitaxel-resistant colon cancer.

    abstract::In this study, we investigated ALDH1A3, Mcl1, and miR-125a/b expression in HT29 cells and the effect of miR-125a/b on ALDH1A3 and Mcl1 expression. Our results showed that low expression of miR-125a/b and high expression of ALDH1A3 and Mel1 were observed in both ALDH1-positive HT29 and HT29-taxol cells. Overexpression ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357907.2012.743557

    authors: Chen J,Chen Y,Chen Z

    更新日期:2013-01-01 00:00:00

  • Signal transduction pathways involved in the lineage-differentiation of NSCs: can the knowledge gained from blood be used in the brain?

    abstract::Neural stem cells (NSC) are capable of differentiating toward neuronal, astrocytic, oligodendrocytic and glial lineages, depending on their spatial location within the central nervous system (CNS). Although, a lot of knowledge has been gained in the understanding of differentiation-specific signaling in hematopoietic ...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-200039679

    authors: Mondal D,Pradhan L,LaRussa VF

    更新日期:2004-01-01 00:00:00

  • Genetic testing for inherited breast cancer risk in African Americans.

    abstract::As genetic testing for BRCA1 and BRCA2 (BRCA1/2) mutations is increasingly integrated into the clinical management of high-risk women, it will be important to understand barriers and motivations for genetic counseling among women from underserved minority groups to ensure equitable access to these services. Therefore,...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-58819

    authors: Halbert CH,Kessler LJ,Mitchell E

    更新日期:2005-01-01 00:00:00

  • Telomerase and telomeres: from basic biology to cancer treatment.

    abstract::The limited capacity to divide is one of the major differences between normal somatic cells and cancerous cells. This 'finite life span' of somatic cells is closely linked to loss of telomeric DNA at telomeres, the 'chromosome caps' consisting of repeated (7TAGGG) sequences., In more than 85% of advanced cancers, this...

    journal_title:Cancer investigation

    pub_type: 杂志文章,评审

    doi:10.1081/cnv-120000370

    authors: Helder MN,Wisman GB,van der Zee GJ

    更新日期:2002-01-01 00:00:00

  • Radiation recall dermatitis induced by edatrexate in a patient with breast cancer.

    abstract::Enhancement of radiation injury to the skin and mucous membranes has been observed with a number of chemotherapeutic agents. A 32-year-old woman with metastatic breast cancer received local radiation therapy to the lumbosacral area. Six weeks later, systemic edatrexate therapy was initiated and a localized painful ery...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909509024929

    authors: Perez EA,Campbell DL,Ryu JK

    更新日期:1995-01-01 00:00:00

  • Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanced melanoma.

    abstract::Melanoma is an immunoresponsive malignancy. Interleukin-10 (IL-10) is a potent regulator of immunosuppression. The purpose of this research was to define the relationship of serum IL-10 to survival in patients with metastatic melanoma. Forty-one melanoma patients and 50 normal volunteers were analyzed. The median IL-1...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.1081/cnv-100102550

    authors: Nemunaitis J,Fong T,Shabe P,Martineau D,Ando D

    更新日期:2001-01-01 00:00:00

  • Phase II evaluation of amonafide in advanced sarcoma: a Southwest Oncology Group study.

    abstract::Soft tissue sarcomas are generally resistant to most chemotherapeutic agents, and individuals with advanced disease have a poor prognosis. We evaluated amonafide, a new drug that has significant activity against several tumor cell lines, to determine its activity against sarcomas. Amonafide was administered to 18 pati...

    journal_title:Cancer investigation

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.3109/07357909409038230

    authors: Buys SS,Metch B,Balcerzak SP,Neefe JR,Stuckey WJ

    更新日期:1994-01-01 00:00:00

  • The effect of castration on the synthesis and secretion of proteins in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.

    abstract:UNLABELLED:The effect of castration on the incorporation of [35S]methionine into secreted proteins in 7,12-dimethylbenz(a)anthracene (DMBA)-induced rat mammary tumors, was investigated. Biopsy specimens were obtained from 19 tumors, 0, 24, 48, 72, and 96 h after castration. In 14 tumors, castration induced an increase ...

    journal_title:Cancer investigation

    pub_type: 杂志文章

    doi:10.3109/07357909209032762

    authors: Geier A,Hemi R,Beery R,Lunenfeld B

    更新日期:1992-01-01 00:00:00